1
|
Gamal H, Ismail KA, Omar AMME, Teleb M, Abu-Serie MM, Huang S, Abdelsattar AS, Zamponi GW, Fahmy H. Non-small cell lung cancer sensitisation to platinum chemotherapy via new thiazole-triazole hybrids acting as dual T-type CCB/MMP-9 inhibitors. J Enzyme Inhib Med Chem 2024; 39:2388209. [PMID: 39140776 PMCID: PMC11328607 DOI: 10.1080/14756366.2024.2388209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/09/2024] [Revised: 07/16/2024] [Accepted: 07/30/2024] [Indexed: 08/15/2024] Open
Abstract
Cisplatin remains the unchallenged standard therapy for NSCLC. However, it is not completely curative due to drug resistance and oxidative stress-induced toxicity. Drug resistance is linked to overexpression of matrix metalloproteinases (MMPs) and aberrant calcium signalling. We report synthesis of novel thiazole-triazole hybrids as MMP-9 inhibitors with T-type calcium channel blocking and antioxidant effects to sensitise NSCLC to cisplatin and ameliorate its toxicity. MTT and whole cell patch clamp assays revealed that 6d has a balanced profile of cytotoxicity (IC50 = 21 ± 1 nM, SI = 12.14) and T-type calcium channel blocking activity (⁓60% at 10 μM). It exhibited moderate ROS scavenging activity and nanomolar MMP-9 inhibition (IC50 = 90 ± 7 nM) surpassing NNGH with MMP-9 over -2 and MMP-10 over -13 selectivity. Docking and MDs simulated its receptor binding mode. Combination studies confirmed that 6d synergized with cisplatin (CI = 0.69 ± 0.05) lowering its IC50 by 6.89 folds. Overall, the study introduces potential lead adjuvants for NSCLC platinum-based therapy.
Collapse
Affiliation(s)
- Hassan Gamal
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
| | - Khadiga A Ismail
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
- Faculty of Pharmacy, Alamein International University (AIU), Alamein City, Egypt
| | - A-Mohsen M E Omar
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
| | - Mohamed Teleb
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
| | - Marwa M Abu-Serie
- Department of Medical Biotechnology, Genetic Engineering and Biotechnology Research Institute, City of Scientific Research and Technological Applications (SRTA-City), Egypt
| | - Sun Huang
- Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada
| | - Abdalla S Abdelsattar
- Center for Microbiology and Phage Therapy, Zewail City of Sciences and Technology, October Gardens, Giza, Egypt
| | - Gerald W Zamponi
- Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada
| | - Hesham Fahmy
- Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, South Dakota State University, Brookings, SD, USA
| |
Collapse
|
2
|
Ellouz M, Ihammi A, Baraich A, Farihi A, Addichi D, Loughmari S, Sebbar NK, Bouhrim M, A. Mothana R, M. Noman O, Eto B, Chigr F, Chigr M. Synthesis and In Silico Analysis of New Polyheterocyclic Molecules Derived from [1,4]-Benzoxazin-3-one and Their Inhibitory Effect against Pancreatic α-Amylase and Intestinal α-Glucosidase. Molecules 2024; 29:3086. [PMID: 38999038 PMCID: PMC11243342 DOI: 10.3390/molecules29133086] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2024] [Revised: 06/22/2024] [Accepted: 06/24/2024] [Indexed: 07/14/2024] Open
Abstract
This study focuses on synthesizing a new series of isoxazolinyl-1,2,3-triazolyl-[1,4]-benzoxazin-3-one derivatives 5a-5o. The synthesis method involves a double 1,3-dipolar cycloaddition reaction following a "click chemistry" approach, starting from the respective [1,4]-benzoxazin-3-ones. Additionally, the study aims to evaluate the antidiabetic potential of these newly synthesized compounds through in silico methods. This synthesis approach allows for the combination of three heterocyclic components: [1,4]-benzoxazin-3-one, 1,2,3-triazole, and isoxazoline, known for their diverse biological activities. The synthesis procedure involved a two-step process. Firstly, a 1,3-dipolar cycloaddition reaction was performed involving the propargylic moiety linked to the [1,4]-benzoxazin-3-one and the allylic azide. Secondly, a second cycloaddition reaction was conducted using the product from the first step, containing the allylic part and an oxime. The synthesized compounds were thoroughly characterized using spectroscopic methods, including 1H NMR, 13C NMR, DEPT-135, and IR. This molecular docking method revealed a promising antidiabetic potential of the synthesized compounds, particularly against two key diabetes-related enzymes: pancreatic α-amylase, with the two synthetic molecules 5a and 5o showing the highest affinity values of 9.2 and 9.1 kcal/mol, respectively, and intestinal α-glucosidase, with the two synthetic molecules 5n and 5e showing the highest affinity values of -9.9 and -9.6 kcal/mol, respectively. Indeed, the synthesized compounds have shown significant potential as antidiabetic agents, as indicated by molecular docking studies against the enzymes α-amylase and α-glucosidase. Additionally, ADME analyses have revealed that all the synthetic compounds examined in our study demonstrate high intestinal absorption, meet Lipinski's criteria, and fall within the required range for oral bioavailability, indicating their potential suitability for oral drug development.
Collapse
Affiliation(s)
- Mohamed Ellouz
- Laboratory of Molecular Chemistry, Materials and Catalysis (LCMMC), Faculty of Sciences and Technology, Sultan Moulay Slimane University, P.O. Box 523, Beni-Mellal 23000, Morocco; (D.A.); (S.L.); (M.C.)
| | - Aziz Ihammi
- Laboratory of Molecular Chemistry, Materials and Catalysis (LCMMC), Faculty of Sciences and Technology, Sultan Moulay Slimane University, P.O. Box 523, Beni-Mellal 23000, Morocco; (D.A.); (S.L.); (M.C.)
| | - Abdellah Baraich
- Laboratory of Bioresources, Biotechnology, Ethnopharmacology and Health, Faculty of Sciences, Mohammed First University, Boulevard Mohamed VI, P.O. Box 717, Oujda 60000, Morocco;
| | - Ayoub Farihi
- Laboratory of Biology and Health, Faculty of Sciences, Ibn Tofail University, Kenitra 14000, Morocco;
- Oriental Center for Water and Environmental Sciences and Technologies (COSTE), Mohammed Premier University, Oujda 60000, Morocco
| | - Darifa Addichi
- Laboratory of Molecular Chemistry, Materials and Catalysis (LCMMC), Faculty of Sciences and Technology, Sultan Moulay Slimane University, P.O. Box 523, Beni-Mellal 23000, Morocco; (D.A.); (S.L.); (M.C.)
| | - Saliha Loughmari
- Laboratory of Molecular Chemistry, Materials and Catalysis (LCMMC), Faculty of Sciences and Technology, Sultan Moulay Slimane University, P.O. Box 523, Beni-Mellal 23000, Morocco; (D.A.); (S.L.); (M.C.)
| | - Nada Kheira Sebbar
- Laboratory of Organic and Physical Chemistry, Applied Bioorganic Chemistry Team, Faculty of Sciences, Ibnou Zohr University, Agadir 80000, Morocco;
| | - Mohamed Bouhrim
- Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal 23000, Morocco; (M.B.); (F.C.)
- Laboratoires TBC, Laboratory of Pharmacology, Pharmacokinetics, and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, P.O. Box 83, F-59000 Lille, France;
| | - Ramzi A. Mothana
- Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (R.A.M.); (O.M.N.)
| | - Omar M. Noman
- Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia; (R.A.M.); (O.M.N.)
| | - Bruno Eto
- Laboratoires TBC, Laboratory of Pharmacology, Pharmacokinetics, and Clinical Pharmacy, Faculty of Pharmaceutical and Biological Sciences, P.O. Box 83, F-59000 Lille, France;
| | - Fatiha Chigr
- Biological Engineering Laboratory, Faculty of Sciences and Techniques, Sultan Moulay Slimane University, Beni Mellal 23000, Morocco; (M.B.); (F.C.)
| | - Mohammed Chigr
- Laboratory of Molecular Chemistry, Materials and Catalysis (LCMMC), Faculty of Sciences and Technology, Sultan Moulay Slimane University, P.O. Box 523, Beni-Mellal 23000, Morocco; (D.A.); (S.L.); (M.C.)
| |
Collapse
|
3
|
Farghaly TA, Abbas EMH, Al-Sheikh MA, Medrasi HY, Masaret GS, Pashameah RA, Qurban J, Harras MF. Synthesis of tricyclic and tetracyclic benzo[6,7]cycloheptane derivatives linked morpholine moiety as CDK2 inhibitors. Drug Dev Res 2023; 84:1127-1141. [PMID: 37170788 DOI: 10.1002/ddr.22074] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/07/2023] [Revised: 03/11/2023] [Accepted: 04/29/2023] [Indexed: 05/13/2023]
Abstract
With the aim of developing cyclin-dependent kinase 2 (CDK2) inhibitors with strong antibreast cancer efficacy, new tricyclic and tetracyclic benzo[6,7]cycloheptane derivatives were synthesized. The newly synthesized tri- and tetracyclic derivatives were achieved from the reaction of 4-(4-morpholin-4-yl-phenyl)-1,3,4,5,6,7-hexahydro-benzo[6,7]cyclohepta[1,2-d]pyrimidine-2-thione (5) with α-haloketone derivatives as hydrazonyl chlorides, phenacyl bromide derivatives, chloroacetone, and ethyl substituted acetate derivatives. The MCF-7 and MDA-MB-231 breast cancer cell lines were utilized to examine the anticancer properties. Compounds 5 and 8 were shown to be the most effective, with half-maximal inhibitory concentration (IC50 ) values between 5.73 and 9.11 µM, which are on the level with doxorubicin. Mechanistic studies showed that 5 and 8 caused tumor cell death by inducing apoptosis and they also produced cancer arrest in the S phase of the cell cycle. In addition, compounds 5 and 8 showed strong anti-CDK2 action (IC50 = 0.112 and 0.18 µM, respectively) comparable to roscovitine (IC50 = 0.127 µM). Moreover, the docking result demonstrated that derivatives 5 and 8 fit into the CDK2 active site in the proper orientation.
Collapse
Affiliation(s)
- Thoraya A Farghaly
- Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Eman M H Abbas
- Chemistry of National and Microbial Products Department, National Research Centre, Giza, Egypt
| | - Mariam A Al-Sheikh
- Department of Chemistry, Faculty of Science, University of Jeddah, AlFaisaliah, Jeddah, Saudi Arabia
| | - Hanadi Y Medrasi
- Department of Chemistry, Faculty of Science, University of Jeddah, Jeddah, Saudi Arabia
| | - Ghada S Masaret
- Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Rami Adel Pashameah
- Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Jihan Qurban
- Department of Chemistry, Faculty of Applied Science, Umm Al-Qura University, Makkah, Saudi Arabia
| | - Marwa F Harras
- Department of Pharmaceutical Medicinal Chemistry and Drug Design, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt
| |
Collapse
|
4
|
El Malah T, Farag H, Awad HM, Abdelrahman MT, Shamroukh AH. Design and Click Synthesis of Novel 1- Substituted-4-(3,4-Dimethoxyphenyl)-1 H-1,2,3-Triazole Hybrids for Anticancer Evaluation and Molecular Docking. Polycycl Aromat Compd 2022. [DOI: 10.1080/10406638.2022.2137205] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Affiliation(s)
- Tamer El Malah
- Photochemistry Department, Chemical Industries Research Institute, National Research Centre, Cairo, Egypt
| | - Hanaa Farag
- Pesticide Chemistry Department, Chemical Industries Research Institute, National Research Centre, Cairo, Egypt
| | - Hanem Mohamed Awad
- Department of Tanning Materials and Leather Technology, National Research Centre, Cairo, Egypt
| | - Mohamad Taha Abdelrahman
- Radioisotopes Department, Nuclear Research Centre, Egyptian Atomic Energy Authority, Cairo, Egypt
| | - Ahmed Hussien Shamroukh
- Photochemistry Department, Chemical Industries Research Institute, National Research Centre, Cairo, Egypt
| |
Collapse
|
5
|
Mareddy J, Hossain KA, Yadav NS, Banothu V, Anireddy JS, Pal S. Novel molecules containing structural features of NSAIDs and 1,2,3-triazole ring: Design, synthesis and evaluation as potential cytotoxic agents. J Mol Struct 2021. [DOI: 10.1016/j.molstruc.2021.131222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
6
|
Khoshnoud A, Pourali AR. Three-Component Synthesis of 1,4-Disubstituted 1,2,3-Triazoles using a Novel and Efficient Nano Alumina Based Cu(II) Catalyst. ORG PREP PROCED INT 2021. [DOI: 10.1080/00304948.2021.1971475] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Amin Khoshnoud
- School of Chemistry, Damghan University, Damghan 36715-364, Iran
| | - Ali Reza Pourali
- School of Chemistry, Damghan University, Damghan 36715-364, Iran
| |
Collapse
|
7
|
Varala R, Bollikolla HB, Kurmarayuni CM. Synthesis of Pharmacological Relevant 1,2,3-Triazole and its Analogues-A Review. Curr Org Synth 2021; 18:101-124. [DOI: 10.2174/1570179417666200914142229] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/14/2020] [Revised: 07/28/2020] [Accepted: 08/06/2020] [Indexed: 11/22/2022]
Abstract
In this review, authors focus mostly on the various synthetic strategies developed so far for 1,2,3-
triazole scaffold and its derivatives via different approaches such as metal-free, metal assisted or bimetallic. A
brief overview of applications of the very important 1,2,3-triazole scaffold along with pharmacological activity is
also discussed. Synthetic strategies are updated until June 2020.
Collapse
Affiliation(s)
- Ravi Varala
- Scrips Pharma, Mallapur, Hyderabad, Telangana-500 076, India
| | | | | |
Collapse
|